COVID-19 Resource Center for Infectious Disease Clinicians

Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 6, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID prevention and treatment in special populations and patients with certain comorbidities.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 18, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 symptoms and clinical manifestations.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 17, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on treatments for COVID-19, including authorized and investigational agents.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 10, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 variants and vaccinations for COVID-19, including authorized and investigational agents.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: March 10, 2022

In this module, expert faculty answer healthcare professionals’ questions about COVID-19 prevention, screening, diagnosis, disease management, and treatment. New questions will be added and responses will be further developed as more data emerge.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: December 16, 2021

Hear expert insights on why extra doses and boosters of the SARS-CoV-2 vaccines are recommended for certain populations, and learn recommendations regarding mixing and matching booster doses.

Renslow Sherer, MD Released: December 8, 2021

Hear expert insights on the rationale for the use of monoclonal antibodies for postexposure prophylaxis in high-risk populations.

Arthur Kim, MD Released: December 15, 2021

Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: January 6, 2022

Hear expert insights on a stepwise approach to evaluate treatment candidacy for oral antiviral agents for COVID-19 and practical considerations for their use.

Kristen Marks, MD Released: February 3, 2022

Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.

Arthur Kim, MD Released: February 21, 2022

Get expert insights on the symptoms, causes, risk factors, timeline, and treatment considerations for long COVID, or postacute sequelae of COVID-19 infection.

Renslow Sherer, MD Released: March 30, 2022

The ever-evolving COVID-19 vaccination landscape has created many questions about who should receive additional vaccine doses, when, and why. Hear expert faculty discuss COVID-19 vaccination efficacy, the rationale for third doses and booster doses, and the data behind mixing and matching of booster doses.

Renslow Sherer, MD Released: December 10, 2021

Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19.

Renslow Sherer, MD Released: January 6, 2022

Do COVID-19 treatments retain their efficacy against the SARS-CoV-2 omicron variant? Hear expert faculty discuss the use of direct-acting, small-molecule antiviral agents and monoclonal antibodies during the omicron era.

Arthur Kim, MD Released: January 25, 2022

Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: February 22, 2022

Long COVID is a syndrome that can occur in some patients following their COVID-19 infection. Hear expert faculty discuss what is known to date about long COVID, including potential causes, risk factors, signs and symptoms, and treatment strategies under consideration.

Renslow Sherer, MD Released: April 13, 2022